The HHS Office of Inspector General is planning a review of whether CMS considers national security risks when certifying labs that conduct genomic testing. The review is in response to concerns from Senate Finance Chair Chuck Grassley (R-IA) and Sen. Marco Rubio (R-FL) that CMS may be paying for genetic testing conducted by U.S. entities partnered with companies tied to the Chinese government. “In response to your request, we are planning a review of CMS controls to determine whether CMS...